Key facts
- Moa Technology’s last known valuation is $97.3M (May 2022).
- It has raised $103.3M; the latest was Later Stage VC ($40.5M) in Dec 2024.
- Notable investors include BGF (Financial Services), Parkwalk Advisors, University of Oxford, Oxford Science Enterprises, Lansdowne Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Moa Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Moa Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Moa Technology
Developer of a crop protection discovery platform designed to offer sustainable herbicide chemistries with new modes of action from both natural and synthetic sources. The company's platform leverages proprietary technologies for herbicide discovery that use an in vivo plant-based genomic patented process to identify the precise target protein associated with a new mode of action, enabling farmers to have a diverse choice of innovative technologies for weed control.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2017
- Employees
- 86
- Website
- moa-technology.com/
- Ownership
- Privately Held (backing)
Moa Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Moa Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Moa Technology in its N-PORT filings yet. We sweep new filings monthly.